TERESA BOWMAN: Open Payments
NPI 1831321793 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,791 in 83 payments from 21 companies in 2025. Trend: 2023 $1,644 · 2024 $1,579 · 2025 $1,791
Food & beverage: $1,701Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $225 |
| ABBVIE INC. | 10 | $215 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $161 |
| GENZYME CORPORATION | 6 | $146 |
| Regeneron Healthcare Solutions, Inc. | 3 | $107 |
| Galderma Laboratories, L.P. | 6 | $104 |
| UCB, Inc. | 3 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| Botanix SB Inc | 4 | $79 |
| Lilly USA, LLC | 4 | $78 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, NEMLUVIO, Bimzelx, ILUMYA, SOFDRA, OPZELURA.
Industry payments across FL — which companies pay providers there.
